Armata Pharmaceuticals, Inc. (ARMP)

[ehihub]

Is this an update to the prospectus or in addition too. I’m asking because it didn’t reference being tied to the prospectus filed yesterday:

Also, Lesgetrich and zoomilk great insight! Thanks for sharing your knowledge.

Latest filling this morning,

AmpliPhi Biosciences Corporation (NYSE American: APHB), a clinical-stage biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant infections, today announced the pricing of a public offering of 4,000,000 shares of its common stock, offered at a price to the public of $1.00 per share, for gross proceeds of $4.0 million, before deducting placement agent fees and offering expenses payable by AmpliPhi. The offering is expected to close on or about January 12, 2018, subject to customary closing conditions.